ImmunityBio
IBRX
NASDAQ
IPO2021
about IBRX
ImmunityBio is a biotechnology company focused on developing innovative cancer immunotherapies and vaccines for infectious diseases using proprietary immune cell activation platforms.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $4.70 | $5.58 | $4.38 | $5.4B | 182.29M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.07 | n/a | 178.35 | -173.51% | -209.83% | 0% |